IP Library Granted Patent US 9,605,001
Granted Patent B2
US 9,605,001 · App. 14/635,979 · Granted Mar 28, 2017

Production of polyketides and other natural products

Inventors: Matthew Alan Gregory (Cambridge, GB); Steven James Moss (Cambridge, GB)
Assignee: Buck Institute for Research On Aging
C07D498/18C07D405/12C07D471/18C07D487/18C07D493/18C07K14/36C12N15/52C12N15/70C12N15/76C12P17/188
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,605,001
App. No.
14/635,979
Granted
Mar 28, 2017
Kind
B2
Abstract

The present invention relates to production of polyketides and other natural products and to libraries of compounds and individual novel compounds. One important area is the isolation and potential use of novel FKBP-ligand analogues and host cells that produce these compounds. The invention is particularly concerned with methods for the efficient transformation of strains that produce FKBP analogues and recombinant cells in which cloned genes or gene cassettes are expressed to generate novel compounds such as polyketide (especially rapamycin) FKBP-ligand analogues, and to processes for their preparation, and to means employed therein (e.g. nucleic acids, vectors, gene cassettes and genetically modified strains).

Claims (55)

1. A compound according to the formula

wherein:

R 1 is H, R 2 is OH, and R 3 is OCH3; or

R 1 is H, R 2 is OH, and R 3 is OH; or

R 1 is H, R 2 is OCH 3 and R 3 is OH; or

R 1 is H, R 2 is H, and R 3 is OCH 3 ; or

R 1 is CH 3 , R 2 is OH, and R 3 is OH; or

R 1 is H, R 2 is OCH 3 , and R 3 is OCH 3 ; or

R 1 is CH 3 , R 2 is OH, and R 3 is OCH 3 ; or

R 1 is CH 3 , R 2 is OCH 3 , and R 3 is OH.

2. The compound of claim 1 , wherein said compound has the formula

3. The compound of claim 1 , wherein

R 1 is H;

R 2 is OH; and

R 3 is OH.

4. The compound of claim 1 , wherein

R 1 is H;

R 2 is OCH 3 ; and

R 3 is OH.

5. The compound of claim 1 , wherein

R 1 is H;

R 2 is H; and

R 3 is OCH 3 .

6. The compound of claim 1 , wherein

R 1 is CH 3 ;

R 2 is OH; and

R 3 is OH.

7. The compound of claim 1 , wherein

R 1 is H;

R 2 is OCH 3 ; and

R 3 is OCH 3 .

8. The compound of claim 1 , wherein

R 1 is CH 3 ;

R 2 is OH; and

R 3 is OCH 3 .

9. The compound of claim 1 , wherein

R 1 is CH 3 ;

R 2 is OCH 3 ; and

R 3 is OH.

10. A compound according to the formula

wherein

R 1 is H, R 2 is H, and R 3 is OH; or

R 1 is H, R 2 is OH, and R 3 is OH.

11. The compound of claim 10 , wherein

R 1 is H;

R 2 is H; and

R 3 is OH.

12. The compound of claim 10 , wherein

R 1 is H;

R 2 is OH; and

R 3 is OH.

13. A method of treating a fungal infection, said method comprising administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising a compound of claim 1 .

14. A method of treating a fungal infection, said method comprising administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising a compound of claim 10 .

15. A method of suppressing an immune response, said method comprising administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising a compound of claim 1 .

16. A method of suppressing an immune response, said method comprising administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising a compound of claim 10 .

Priority Claims (2)
GB 0216509.0 · Jul 16, 2002 · national
GB 0224922.5 · Oct 25, 2002 · national
Continuity (4)
Continuation 13046304 · Mar 11, 2011
Division 11747593 · May 11, 2007
Division 10497135
Related Publication 20150266896A1 · Sep 24, 2015